Interleukin-11 to Enter Phase III

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Multivariate analysis showed consolidative thoracic radiotherapy improved OS/PFS vs control patients with ES-SCLC, with respective HRs of 0.53 and 0.90.

Cristiane Decat Bergerot, PhD

April 14th 2025

Classification System May Identify QOL Benefit with Palliative Radiotherapy

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.

Elevating the Quality of Cancer Care via Cross-Department Collaboration

Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD

April 7th 2025

Optimizing Radiosurgery for CNS Tumors, Insights on Technology and Teamwork

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Ariana Pelosci

Taletrectinib Yields Durable Responses, Prolonged PFS in ROS1+ NSCLC

William Kennedy, MD, discussed modern radiosurgery techniques, technology selection, and the multidisciplinary approach for treating complex CNS tumors.

Tim Cortese

Consolidative Thoracic Radiotherapy Improves Survival in ES-SCLC

Pooled results from the TRUST-I and TRUST-II trials showed that taletrectinib led to infrequent neurological TEAEs in patients with ROS1-positive NSCLC.

Related Content

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Multivariate analysis showed consolidative thoracic radiotherapy improved OS/PFS vs control patients with ES-SCLC, with respective HRs of 0.53 and 0.90.

Cristiane Decat Bergerot, PhD

April 14th 2025

Classification System May Identify QOL Benefit with Palliative Radiotherapy

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

Elevating the Quality of Cancer Care via Cross-Department Collaboration

Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD

April 7th 2025

Optimizing Radiosurgery for CNS Tumors, Insights on Technology and Teamwork

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Ariana Pelosci

Taletrectinib Yields Durable Responses, Prolonged PFS in ROS1+ NSCLC

William Kennedy, MD, discussed modern radiosurgery techniques, technology selection, and the multidisciplinary approach for treating complex CNS tumors.

Tim Cortese